KHAI Ventures Secures Exclusive Rights to 17 Million Pediatric Patient Dataset
KHAI Ventures has secured an exclusive agreement to commercialize and distribute Futureheal's proprietary pediatric dataset, covering 17 million unique patient records across the Americas. The data will be used to train the company's healthcare AI portfolio.

KHAI Ventures has obtained exclusive rights to commercialize and distribute Futureheal's proprietary pediatric dataset, which includes 17 million unique patient records from across the Americas. KHAI plans to leverage this extensive longitudinal data to train and develop clinical artificial intelligence (AI) models within its diverse healthcare portfolio.
The agreement, announced Tuesday, grants KHAI Ventures sole commercialization and distribution authority over the dataset. Specific financial terms and the timeline for integrating the data into KHAI's AI development pipelines were not disclosed.
Access to such a comprehensive longitudinal dataset of pediatric patient information is critical for advancing AI-driven healthcare solutions. It can enable faster diagnoses, improved treatment pathways, and the development of more accurate predictive models for children's health.
KHAI Ventures aims to enhance healthcare efficiency and patient outcomes through data-driven strategies. The acquisition of this significant dataset is expected to substantially bolster the development and validation of its existing and future AI algorithms in the healthcare sector.